Search - tctmd.com

Displaying 101 - 120 of 347

Sort: Relevancy | Date

Presentation TCT 2022

Changes in Disease Patterns and Demographics in Cardiovascular Disease: Time to Re-evaluate Innovation Priorities?

Presenter: Reza Mohebi

September 16, 2022

News Daily News

Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes

Todd Neale

September 14, 2022

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

News Daily News

Higher Step Counts Equal Better CV Health: UK Biobank

Caitlin E. Cox

September 13, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

VITAL Rhythm Data May Flip the Script on AF Screening in Women

L.A. McKeown

September 08, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

Presentation ESC 2022

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Presenter: Michelle L. O’Donoghue

August 29, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

Advertisement

Changes in Disease Patterns and Demographics in Cardiovascular Disease: Time to Re-evaluate Innovation Priorities?

Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Higher Step Counts Equal Better CV Health: UK Biobank

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

VITAL Rhythm Data May Flip the Script on AF Screening in Women

CV Care Around Noncardiac Surgery: New ESC Guidelines

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

September 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for August 2022

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content